US2007299035A1PendingUtilityA1

Use of chemical chelators as reversal agents for drug-induced neuromuscular block

Assignee: ORGANON NVPriority: Aug 13, 1999Filed: Jul 19, 2007Published: Dec 27, 2007
Est. expiryAug 13, 2019(expired)· nominal 20-yr term from priority
A61P 39/04A61P 25/00A61P 25/30A61K 31/194A61K 31/724A61P 21/02A61P 21/00
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to the use of chemical chelators for the preparation of a medicament for the reversal of drug-induced neuromuscular block, to a kit for providing neuromuscular block and its reversal, and to cyclophane derivatives having the general formula A wherein R is the general formula B wherein X is or a pharmaceutically acceptable salt thereof.

Claims

exact text as granted — not AI-modified
1 - 33 . (canceled)  
   
   
       34 . A method for reversal of drug-induced neuromuscular block in a patient caused by clinically-used neuromuscular blocking agent which acts by reversible binding to the acetylcholine receptor, comprising parenterally administering to said patient an effective amount of a chemical chelator capable of forming a guest-host complex with the neuromuscular blocking agent, wherein the association constant of said guest-host in an aqueous medium at ambient temperature is higher than 10.000 M-1.  
   
   
       35 . The method according to  claim 34 , wherein the neuromuscular blocking agent is selected from the group consisting of rocuronium, vecuronium, pancuronium, rapacuronium, mivacurium, (cis)atracurium and tubocurarine.  
   
   
       36 . The method according to  claim 34 , wherein the chemical chelator is selected from the group consisting of cyclic oligosaccharides and cyclophanes.  
   
   
       37 . The method according to  claim 34 , wherein the chemical chelator is gamma-cyclodextrin or a derivative thereof.  
   
   
       38 . The method according to  claim 34 , wherein the neuromuscular blocking agent is selected from the group consisting of rocuronium and vecuronium and the chemical chelator is gamma-cyclodextrin or a derivative thereof.

Join the waitlist — get patent alerts

Track US2007299035A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.